България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾
False /oidc-signin/en-gb/ България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾

Redefining Foam with ConvaFoam™

Redefining Superior Performance*¹

icon

Absorption

icon

Easy removal

icon

Adhesion

icon

Longer wear time

At Convatec, we listened, innovated, and designed a better care experience by redefining what a foam dressing can do:

Introducing NEW ConvaFoam™

The only affordable foam dressing that combines our three technologies:

  • Aquacel© Hydrofiber™
  • Superabsorber fibres
  • ConvaTac™ silicone

To deliver superior*1 exudate management with skin friendly adhesion3 for longer lasting wear times*1 which optimises healthcare efficiency.4

ConvaFoam™ has superior 7-day fluid handling capacity*1

  • ConvaFoam™ demonstrates greater 7-day fluid-handling capacity compared to other dressings tested, including Mepilex Border, Allevyn Gentle Border, Allevyn Life and Optifoam Border SA.1
  • Higher moisture vapour transmission rate prevents ConvaFoam™ from saturating too quickly. This potentially increases comfort for the patient and reduces the frequency of dressing changes, resulting in possible cost savings.4

ConvaFoam™ with new ConvaTac™ silicone offers superior adhesive strength*1

  • ConvaFoam™ has greater adhesive strength compared to other dressings tested, including Mepilex Border Comfort, Allevyn Gentle Border, Biatain Silicone and Optifoam Gentle Border SA1
  • ConvaTac™ ensures your dressing remains in place – while being skin friendly.3

The new ConvaFoam™ range

ConvaFoam™ is designed to address your needs and those of your patients and can be used on an extensive range of wound types.

Redefined for your needs – and those of your patients

ConvaFoam™ is designed to address your needs and those of your patients and can be used on an extensive range of wound types. 

icon

Absorption

Superior*1 absorption, retention and fluid handling – for superior*1 exudate management

icon

Easy removal

Minimises pain on removal, increasing patient comfort4

icon

Longer wear time

7-day wear time1 reduces the number of dressing changes, optimising healthcare resources3

icon

Adhesion

Superior*1, skin-friendly adhesive strength that maximises wear time2

ConvaFoam™ as part of Wound Hygiene

Find out how you can improve outcomes for your patients with our Wound Hygiene protocol of care

Still Perfect Partners

ConvaFoam™ dressings are indicated to be used as either a primary or a secondary dressing by combining it with our Aquacel® Hydrofiber® range for deeper wounds or wounds with a higher risk of infection6.

References:

* vs selected dressings tested in vitro for absorption, retention, fluid handling and adhesion.

  1. WHRI9478 MS186_DHF1093 ConvaFoam Superiority Report Testing between May 2021 – June 2022.
  2. Kantar, Health Division 1st March 2021 Ref: 260415119
  3. WHRI8050 MS172 Adhesion Characteristics of ConvaFoam.
  4. Wounds UK Best Practice Statement. Effective exudate management. London: Wounds UK, 2013. Available to download from: www.wounds-uk.com
  5. WHRI8196 MS176 ConvaFoam Pore Size
  6. WHRI8051 MS173 In-vitro Performance Characteristics of ConvaFoam
  7. Hoekstra MJ, Hermans MH, Richters CD, Dutrieux RP. A histological comparison of acute inflammatory responses with a hydrofibre or tulle gauze dressing. J Wound Care. 2002;11(3):113‐117.
  8. Coutts P, Sibbald RG. The effect of a silver-containing Hydrofiber dressing on superficial wound bed and bacterial balance of chronic wounds. Int Wound J. 2005;2(4):348-356
  9. Walker M, Hobot JA, Newman GR, Bowler PG. Scanning electron microscopic examination of bacterial immobilisation in a carboxymethyl cellulose (AQUACEL®) and alginate dressings. Biomaterials. 2003;24(5):883‐890.
  10. Caruso DM, Foster KN, Blome‐Eberwein SA, et al. Randomized clinical study of Hydrofiber® dressing with silver or silver sulfadiazine in the management of partial thickness burns. J Burn Care Res. 2006
  11. Soft Silicone Dressings Made Easy, Meuleneire F, Rucknagel H, Wounds International, May 2013
  12. ConvaFoam IFU

AP-70128-GBL-ENG-v1 Date of preparation: July 2024

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?